Diagnostics & Scientific Suppliers Profile
Key Indicators
- Authorised Capital ₹ 2.00 M
as on 02-12-2024
- Paid Up Capital ₹ 2.00 M
as on 02-12-2024
- Company Age 14 Year, 5 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 3.75 Cr
as on 02-12-2024
- Satisfied Charges ₹ 1.11 Cr
as on 02-12-2024
- Revenue -3.40%
(FY 2020)
- Profit 7.10%
(FY 2020)
- Ebitda 20.51%
(FY 2020)
- Net Worth 22.16%
(FY 2020)
- Total Assets 9.68%
(FY 2020)
About Diagnostics & Scientific Suppliers
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 2.00 M and a paid-up capital of Rs 2.00 M.
The company currently has active open charges totaling ₹3.75 Cr. The company has closed loans amounting to ₹1.11 Cr, as per Ministry of Corporate Affairs (MCA) records.
Pradeep Sapra, Yogita Sapra, Mukta Wadhawan, and One other member serve as directors at the Company.
- CIN/LLPIN
U52310CH2010PTC032378
- Company No.
032378
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
03 Aug 2010
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Chandigarh
Industry
Company Details
- Location
Chandigarh, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Diagnostics & Scientific Suppliers?
Board Members(4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Pradeep Sapra  | Director | 03-Aug-2010 | Current |
| Yogita Sapra | Director | 17-Aug-2018 | Current |
| Mukta Wadhawan | Director | 17-Aug-2018 | Current |
| Rajeshwar Wadhwan | Director | 03-Aug-2010 | Current |
Financial Performance of Diagnostics & Scientific Suppliers.
Diagnostics & Scientific Suppliers Private Limited, for the financial year ended 2020, experienced Minor drop in revenue, with a 3.4% decrease. The company also saw a slight improvement in profitability, with a 7.1% increase in profit. The company's net worth Soared by an impressive increase of 22.16%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Diagnostics & Scientific Suppliers?
In 2020, Diagnostics & Scientific Suppliers had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Hdfc Bank Limited Creation Date: 20 Mar 2024 | ₹1.50 Cr | Open |
City Union Bank Limited Creation Date: 06 Jul 2020 | ₹2.00 M | Open |
City Union Bank Limited Creation Date: 30 Nov 2017 | ₹5.50 M | Open |
How Many Employees Work at Diagnostics & Scientific Suppliers?
Unlock and access historical data on people associated with Diagnostics & Scientific Suppliers, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Diagnostics & Scientific Suppliers, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Diagnostics & Scientific Suppliers's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
